FeNO as a biomarker of interstitial and fibrotic pulmonary sequelae in patients admitted for severe SARS-CoV-2 pneumonia

FeNO as a biomarker of interstitial and fibrotic pulmonary sequelae in patients admitted for severe SARS-CoV-2 pneumonia

Abstract Pulmonary fibrosis after severe SARS-CoV-2 pneumonia is a major sequela in surviving patients which requires evaluation. Fractional exhaled nitric oxide (FeNO) is a marker of airway inflammation, easy to obtain and available in most functional testing laboratories of pulmonology services. O...

Full description

Saved in:
Bibliographic Details
Main Authors: Diego Ferrer-Pargada, Carlos A. Amado, Beatriz Abascal-Bolado, Sandra Tello Mena, Pilar Alonso Lecue, Carlos Armiñanzas, Francisco Arnaiz de las Revillas, Miguel Santibáñez, Juan Agüero, Víctor Fernández Lobo, J. Gonzalo Ocejo-Vinyals, José Manuel Cifrian
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
FeNO
COVID-19
SARS-CoV-2
Sequeale
ILD
Pulmonary fibrosis
Online Access:https://doi.org/10.1038/s41598-025-09229-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items